Get started
Author

Inés Asunción Losada López

Observed names: I Losada-López, I. Losada-López, I. Losada‐López, Ines Losada, Ines Losada Lopez, Ines Losada-Lopez, Inès Losada, Inés A. Losada, Inés Asunción Losada-López, Inés Losada, Inés Losada López, Inés Losada-López, Inês Losada Lopez
ORCID: 0000-0002-4834-0843
Observed ORCID: 0000-0002-4834-0843
OpenAlex ID: A5038734859
Long-term safety and efficacy of patisiran for hereditary transthyretin-mediated amyloidosis with polyneuropathy: 12-month results of an open-label extension study
2020 · David Adams, Michael Polydefkis, et al. · The Lancet Neurology · 165
PDF
Rapidly progressive interstitial lung disease due to anti-MDA5 antibodies without skin involvement: a case report and literature review
2018 · Juan González-Moreno, Manuel Raya-Cruz, et al. · Rheumatology International · 54
PDF
Bisphosphonates in patients with autoimmune rheumatic diseases: Can they be used in women of childbearing age?
2010 · Inès Losada, Leonardo Sartori, et al. · Autoimmunity Reviews · 53
Polyserositis: a diagnostic challenge
2018 · Inés Losada, Juan González‐Moreno, et al. · Internal Medicine Journal · 33
A Descriptive Analysis of ATTR Amyloidosis in Spain from the Transthyretin Amyloidosis Outcomes Survey
2021 · Juan González-Moreno, Inés Losada-López, et al. · Neurology and Therapy · 30
PDF
IGRA testing in patients with immune-mediated inflammatory diseases: which factors influence the results?
2017 · Juan González-Moreno, Mercedes García-Gasalla, et al. · Rheumatology International · 24
Serosal involvement in IgG4-related disease: report of two cases and review of the literature
2016 · Juan González-Moreno, Inés Losada-López, et al. · Rheumatology International · 19
Val50Met hereditary transthyretin amyloidosis: not just a medical problem, but a psychosocial burden
2021 · Juan González-Moreno, Aina Gaya-Barroso, et al. · Orphanet Journal of Rare Diseases · 18
PDF
Anticipation on age at onset in kindreds with hereditary ATTRV30M amyloidosis from the Majorcan cluster
2020 · Eugenia Cisneros-Barroso, Juan González-Moreno, et al. · Amyloid · 14
PDF
A multicentric study of the disease risks and first manifestations in hereditary transthyretin amyloidosis (ATTRv): insights for an earlier diagnosis
2023 · Violaine Planté-Bordeneuve, Farida Gorram, et al. · Amyloid · 13
Mannose‐binding lectin exon 1 and promoter polymorphisms in tuberculosis disease in a mediterranean area
2014 · M. García‐Gasalla, J. Milá Llambí, et al. · International Journal of Immunogenetics · 13
Biomarkers of axonal damage to favor early diagnosis in variant transthyretin amyloidosis (A-ATTRv)
2024 · Juan González-Moreno, Álvaro Gragera-Martínez, et al. · Scientific Reports · 11
PDF
Predictive Immunological, Virological, and Routine Laboratory Markers for Critical COVID-19 on Admission
2021 · Immunocovid study, Mercedes García-Gasalla, et al. · Canadian Journal of Infectious Diseases and Medical Microbiology · 11
PDF
Multidisciplinary approach in the management of hATTR
2020 · Ines Losada, Juan González‐Moreno, et al. · European Journal of Clinical Investigation · 11
Bacteriemia por anaerobios estrictos: estudio de 68 pacientes
2009 · Antoni Bassa, Mercedes García-Gasalla, et al. · Enfermedades Infecciosas y Microbiología Clínica · 10
Hyperinflammatory Immune Response in COVID-19: Host Genetic Factors in Pyrin Inflammasome and Immunity to Virus in a Spanish Population from Majorca Island
2023 · Natalia Martínez-Pomar, Vanesa Cunill, et al. · Biomedicines · 9
PDF
Enfermedad relacionada con IgG4
2015 · Juan González-Moreno, Inés Losada López, et al. · Medicina Clínica · 9
Accessibility to Occupational Therapy Services for Hereditary Transthyretin Amyloidosis
2022 · Aina Gayà-Barroso, Juan González-Moreno, et al. · International Journal of Environmental Research and Public Health · 8
PDF
Significant reduction in proteinuria after treatment with tafamidis
2019 · Asuncion Ferrer-Nadal, Tomas Ripoll, et al. · Amyloid · 8
A narrative review and expert recommendations on the assessment of the clinical manifestations, follow-up, and management of post-OLT patients with ATTRv amyloidosis
2023 · Carlos Casasnovas, Laura Lladó, et al. · Therapeutic Advances in Neurological Disorders · 7
PDF
Establishing Occupational Therapy Needs: A Semi-Structured Interview with Hereditary Transthyretin Amyloidosis Patients
2022 · Aina Gayà-Barroso, Juan González-Moreno, et al. · International Journal of Environmental Research and Public Health · 7
PDF
A description of variant transthyretin amyloidosis (ATTRv) stage 1 patients and asymptomatic carriers in Spain: the EMPATIa study
2024 · Lucía Galán Dávila, Fernando Martinez Valle, et al. · Orphanet Journal of Rare Diseases · 6
PDF
Validating the usefulness of Sudoscan in ATTRv: a single centre experience
2024 · Elena Moreno-Moraleda, Juan González-Moreno, et al. · Neurological Sciences · 6
Mannose binding lectin polymorphisms in systemic lupus erythematosus in Spain
2016 · Inés Losada López, Mercedes García Gasalla, et al. · European Journal of Inflammation · 6
PDF
Tuberculosis cutánea en una zona de Mallorca (2003-2011)
2012 · I. Losada-López, M. García-Gasalla, et al. · Revista Clínica Española · 6
Works count: 62
Citation count: 755
H-index: 12
I10-index: 16
Year
Topic
Type